Evidence map›Paper›PMID 34795016›Full record

ArticleLife science alliance2022

Existence of log-phase

Mikkel Skjoldan Svenningsen, Sine Lo Svenningsen, Michael Askvad Sørensen, Namiko Mitarai

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Survival ofFrontiers in microbiology · 2023
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mikkel Skjoldan SvenningsenThe Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark.
Sine Lo SvenningsenThe Department of Biology, University of Copenhagen, Copenhagen, Denmark.
Michael Askvad SørensenThe Department of Biology, University of Copenhagen, Copenhagen, Denmark mas@bio.ku.dk.ORCID 0000-0001-8931-2999
Namiko MitaraiThe Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark mitarai@nbi.ku.dk.ORCID 0000-0003-0116-7606
University of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The vast majority of a bacterial population is killed when treated with a lethal concentration of antibiotics. The time scale of this killing is often comparable with the bacterial generation time before the addition of antibiotics. Yet, a small subpopulation typically survives for an extended period. However, the long-term killing dynamics of bacterial cells has not been fully quantified even in well-controlled laboratory conditions. We constructed a week-long killing assay and followed the survival fraction of

Indexed as

Anti-Bacterial AgentsCiprofloxacinDose-Response Relationship, DrugEscherichia coliEscherichia coli InfectionsMicrobial ViabilityAnti-Bacterial AgentsCiprofloxacin

Identifiers

PMID34795016
PMCPMC8605324
OpenAlexW3214730028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.